Team
Oli is an associate in our Cambridge office and is part of the Corporate Technology team.
Oli advises a range of companies in the tech and life sciences sectors on a variety of corporate matters, including venture capital investments, fundraisings, M&A and joint ventures.
Since 2021 | Associate, Taylor Wessing |
2019 - 2020 | Associate, Slaughter and May |
2017 - 2019 | Trainee solicitor, Slaughter and May |
2019 | Admitted as a solicitor in England & Wales |
2016 - 2017 | GDL & LPC, BPP Law School |
2012 - 2015 | BA Politics, University of Warwick |
Aktuelle News & Insights
Nuclera raises additional capital for eProtein™ desktop bioprinter to close Series B funding at $58 million
von mehreren Autoren
Advising Placid0 on its acquisition by eyecare brand WALDO
von mehreren Autoren
Advising Nuclera on its Series B funding round
von mehreren Autoren
Advising Cambridge Epigenetix on its $88 million Series D funding round to advance best-in-class DNA sequencing technology platform
von Ross McNaughton und Oli Denne